The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and ...

J.P. Morgan on Wednesday launched its coverage of ANI Pharmaceuticals (NASDAQ:ANIP) with an Overweight recommendation and a ...

Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the ...

JPMorgan initiated coverage of ANI Pharmaceuticals (ANIP) with an Overweight rating and $85 price target ANI is a specialty pharmaceuticals ...

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) ...

The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel (repository corticotropin injection USP) in a prefilled syringe presentation. The new single-dose prefilled syringes ...

ANI Pharmaceuticals, Inc. announced the FDA approval of its Purified Cortrophin® Gel in a prefilled syringe format, aimed at improving patient experience by reducing administration steps.